CNAT - Conatus Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate-0.12-0.09-0.37-0.25
Low Estimate-0.12-0.09-0.37-0.25
High Estimate-0.12-0.09-0.37-0.25
Year Ago EPS-0.15-0.13-0.59-0.37
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate6.5M6M30.31MN/A
Low Estimate6.5M6M30.31MN/A
High Estimate6.5M6M30.31MN/A
Year Ago SalesN/A7.41M33.59M30.31M
Sales Growth (year/est)N/A-19.00%-9.80%N/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.15-0.14-0.12-0.12
EPS Actual-0.15-0.13-0.14-0.02
Difference00.01-0.020.1
Surprise %0.00%7.10%-16.70%83.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.12-0.09-0.37-0.25
7 Days Ago-0.12-0.09-0.37-0.25
30 Days Ago-0.12-0.09-0.37-0.25
60 Days Ago-0.12-0.09-0.37-0.25
90 Days Ago-0.12-0.09-0.48-0.25
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCNATIndustrySectorS&P 500
Current Qtr.20.00%N/AN/A-0.01
Next Qtr.30.80%N/AN/A0.06
Current Year37.30%N/AN/A-0.02
Next Year32.40%N/AN/A0.14
Next 5 Years (per annum)38.00%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A